Search scope:
排序: Display mode:
Obesity-related glomerulopathy: pathogenesis, pathologic, clinical characteristics and treatment
Tianhua Xu, Zitong Sheng, Li Yao
Frontiers of Medicine 2017, Volume 11, Issue 3, Pages 340-348 doi: 10.1007/s11684-017-0570-3
In light of the rapid increase in the number of obesity incidences worldwide, obesity has become an independent risk factor for chronic kidney disease. Obesity-related glomerulopathy (ORG) is characterized by glomerulomegaly in the presence or absence of focal and segmental glomerulosclerosis lesions. IgM and complement 3 (C3) nonspecifically deposit in lesions without immune-complex-type deposits during ORG immunofluorescence. ORG-associated glomerulomegaly and focal and segmental glomerulosclerosis can superimpose on other renal pathologies. The mechanisms under ORG are complex, especially hemodynamic changes, inflammation, oxidative stress, apoptosis, and reduced functioning nephrons. These mechanisms synergize with obesity to induce end-stage renal disease. A slow increase of subnephrotic proteinuria (<3.5 g/d) is the most common clinical manifestation of ORG. Several treatment methods for ORG have been developed. Of these methods, renin–angiotensin–aldosterone system blockade and weight loss are proven effective. Targeting mitochondria may offer a novel strategy for ORG therapy. Nevertheless, more research is needed to further understand ORG.
Keywords: obesity-related glomerulopathy pathogenesis pathologic clinical characteristics
LOU Wenhui, JIN Dayong, WANG Dansong, XU Xuefeng, KUANG Tiantao, QIN Xinyu
Frontiers of Medicine 2007, Volume 1, Issue 2, Pages 173-176 doi: 10.1007/s11684-007-0032-4
Keywords: diameter Pathologic rereview invasive unresectable intraductal papillary
Title Author Date Type Operation
Obesity-related glomerulopathy: pathogenesis, pathologic, clinical characteristics and treatment
Tianhua Xu, Zitong Sheng, Li Yao
Journal Article